|
"jia horng kao"的相关文件
显示项目 811-860 / 1180 (共24页)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Ming-Shiang Wu;Jia-Horng Kao;Wen-Lun Wang;Tzeng-Huey Yang;Chaur-Shine Wang;Ming-Feng Chiang;Chieh-Chang Chen;Yu-Jen Fang;Hsu-Wei Hung;Chun-Ying Wu;Jaw-Town Linhsu, Yao-Chun;Mo, Lein-Ray;Chang, Chi-Yang;Wu, Ming-Shiang;Kao, Jia-Horng;Wang, Wen-Lun;Yang, Tzeng-Huey;Wang, Chaur-Shine;Chiang, Ming-Feng;Chen, Chieh-Chang;Fang, Yu-Jen;Hung, Hsu-Wei;Wu, Chun-Ying;Lin, Jaw-Town; Hsu, Yao-Chun; MING-SHIANG WU; Mo, Lein-Ray; JIA-HORNG KAO; Chang, Chi-Yang; Wu, Ming-Shiang; Wu, Ming-Shiang; Kao, Jia-Horng; Kao, Jia-Horng; Wang, Wen-Lun; Wang, Wen-Lun; Yang, Tzeng-Huey; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chiang, Ming-Feng; Chen, Chieh-Chang; Chen, Chieh-Chang; Fang, Yu-Jen; Fang, Yu-Jen; Hung, Hsu-Wei; Hung, Hsu-Wei; Wu, Chun-Ying; Wu, Chun-Ying; Lin, Jaw-Town |
| 臺大學術典藏 |
2018-09-10T15:35:03Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Yao-Chun Hsu;Lein-Ray Mo;Chi-Yang Chang;Ming-Shiang Wu;Jia-Horng Kao;Wen-Lun Wang;Tzeng-Huey Yang;Chaur-Shine Wang;Ming-Feng Chiang;Chieh-Chang Chen;Yu-Jen Fang;Hsu-Wei Hung;Chun-Ying Wu;Jaw-Town Linhsu, Yao-Chun;Mo, Lein-Ray;Chang, Chi-Yang;Wu, Ming-Shiang;Kao, Jia-Horng;Wang, Wen-Lun;Yang, Tzeng-Huey;Wang, Chaur-Shine;Chiang, Ming-Feng;Chen, Chieh-Chang;Fang, Yu-Jen;Hung, Hsu-Wei;Wu, Chun-Ying;Lin, Jaw-Town; Hsu, Yao-Chun; MING-SHIANG WU; Mo, Lein-Ray; JIA-HORNG KAO; Chang, Chi-Yang; Wu, Ming-Shiang; Wu, Ming-Shiang; Kao, Jia-Horng; Kao, Jia-Horng; Wang, Wen-Lun; Wang, Wen-Lun; Yang, Tzeng-Huey; Yang, Tzeng-Huey; Wang, Chaur-Shine; Chiang, Ming-Feng; Chiang, Ming-Feng; Chen, Chieh-Chang; Chen, Chieh-Chang; Fang, Yu-Jen; Fang, Yu-Jen; Hung, Hsu-Wei; Hung, Hsu-Wei; Wu, Chun-Ying; Wu, Chun-Ying; Lin, Jaw-Town |
| 臺大學術典藏 |
2018-09-10T15:35:02Z |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Cheng, Huei-Ru; Jeng, Yung-Ming; JIA-HORNG KAO; Lin, Hsiu-Lin; Wang, Chih-Chiang; Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Wu, Hui-Lin; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; YUNG-MING JENG; Liu, Chun-Jen; Li, Yung-Tsung; CHUN-JEN LIU; 陳定信;高嘉宏;鄭永銘;吳慧琳;蘇東弘;劉俊人;陳培哲;林琇玲; Li, Y.-T. and Liu, C.-J. and Su, T.-H. and Cheng, H.-R. and Jeng, Y.-M. and Lin, H.-L. and Wang, C.-C. and Kao, J.-H. and Chen, P.-J. and Chen, D.-S. and Wu, H.-L.; Li, Yung-Tsung;Liu, Chun-Jen;Su, Tung-Hung;Cheng, Huei-Ru;Jeng, Yung-Ming;Lin, Hsiu-Lin;Wang, Chih-Chiang;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn;Wu, Hui-Lin; 陳定信;高嘉宏;鄭永銘;吳慧琳;蘇東弘;劉俊人;陳培哲;林琇玲 |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study
|
Chou, Shih-Wan; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Yang, Hung-Chih; Yang, Hung-Chih; Wu, Shang-Ju; Wu, Shang-Ju; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Chi-Ling; Kao, Jia-Horng; Kao, Jia-Horng; 陳祈玲; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Chou, Shih-Wan;Liu, Chen-Hua;Yang, Hung-Chih;Wu, Shang-Ju;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chi-Ling;Kao, Jia-Horng; Su, T.-H. and Liu, C.-J. and Tseng, T.-C. and Chou, S.-W. and Liu, C.-H. and Yang, H.-C. and Wu, S.-J. and Chen, P.-J. and Chen, D.-S. and Chen, C.-L. and Kao, J.-H.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Chou, Shih-Wan;Liu, Chen-Hua;Yang, Hung-Chih;Wu, Shang-Ju;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chi-Ling;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;吳尚儒;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;吳尚儒;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; CHEN-HUA LIU; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Chou, Shih-Wan; TUNG-HUNG SU |
| 臺大學術典藏 |
2018-09-10T15:34:49Z |
Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Liu, Wei-Liang;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; Hsu, Ching-Sheng; Chang, Chia-Hsuin; Hsu, Shih-Jer; Hsu, Shih-Jer; JIA-HORNG KAO; Liu, Wei-Liang; Liu, Wei-Liang; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:27:32Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H. and Liang, C.-C. and Liu, C.-J. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Liu, Chen-Hua; Liang, Cheng-Chao; CHUN-JEN LIU; PEI-JER CHEN; Liu, Chun-Jen; CHEN-HUA LIU; Lin, Chih-Lin; Su, Tung-Hung; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:26:55Z |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng, T.-C. and Liu, C.-J. and Chen, C.-L. and Yang, W.-T. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; Tseng, T. -C.;Liu, C. -J.;Chen, C. -L.;Yang, W. -T.;Yang, H. -C.;Su, T. -H.;Wang, C. -C.;Kuo, S. F. -T.;Liu, C. -H.;Chen, P. -J.;Chen, D. -S.;Kao, J. -H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Chang, C-H.; Tseng, T. -C.; HUNG-CHIH YANG; CHUN-JEN LIU; Liu, C. -J.; PEI-JER CHEN; Chen, C. -L.; Yang, W. -T.; CHEN-HUA LIU; TUNG-HUNG SU; Yang, H. -C.; DING-SHINN CHEN; Su, T. -H.; Wang, C. -C.; JIA-HORNG KAO; Kuo, S. F. -T.; Liu, C. -H.; Chen, P. -J.; Chen, D. -S.; Kao, J. -H. |
| 臺大學術典藏 |
2018-09-10T15:24:59Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.
|
Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Cheng, Huei-Ru; Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; Wu, Hui-Lin; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T15:24:58Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
|
Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; 劉振驊;高嘉宏; 劉振驊;高嘉宏; Wang, Chia-Chi; Hsu, Wan-Tseng; CHEN-HUA LIU; Liu, Chen-Hua; Shen, Li-Jiuan; JIA-HORNG KAO; Liu, Chen-Hua; Lee, Chii-Ming; Lin, Chih-Lin; Lin, Chih-Lin; Wang, Pin-Chao; Wang, Pin-Chao; Tseng, Tai-Chung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Kao, Jia-Horng; Kao, Jia-Horng; 李啟明; 沈麗娟 |
| 臺大學術典藏 |
2018-09-10T15:24:57Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.
|
Chen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, Szu-Min Hsieh, Yi-Chun Lo, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Wen-Chun Liu, Pei-Jer Chen, Ding-Shinn Chen, Chien-Ching Hung, Jia-Horng Kao; Liu, Chen-Hua;Sheng, Wang-Hui;Sun, Hsin-Yun;Hsieh, Szu-Min;Lo, Yi-Chun;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Liu, Wen-Chun;Chen, Pei-Jer;Chen, Ding-Shinn;Hung, Chien-Ching;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;孫幸筠;劉俊人;謝思民;陳培哲;盛望徽;洪健清; Chang, Tien-Jyun; Liu, Chen-Hua; HUNG-CHIH YANG; Sheng, Wang-Hui; CHUN-JEN LIU; Tseng, Hsing-Chi; Sun, Hsin-Yun; Liu, Meng-Wei; SZU-MIN HSIEH; PEI-JER CHEN; Chang, Yi-Cheng; Hsieh, Szu-Min; Hsieh, Meng-Lun; Lo, Yi-Chun; CHEN-HUA LIU; Liu, Chun-Jen; Chuang, Lee-Ming; DING-SHINN CHEN; TUNG-HUNG SU; Su, Tung-Hung; Yang, Hung-Chih; HSIN-YUN SUN; Liu, Wen-Chun; JIA-HORNG KAO; CHIEN-CHING HUNG; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; ?????; ?i?H??; ?i??g; ?????? |
| 臺大學術典藏 |
2018-09-10T15:24:50Z |
Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients
|
Huang, Y.-W.;Yang, S.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:50Z |
Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B
|
Lin, C.-L.;Liu, C.-H.;Wang, C.-C.;Liang, C.-C.;Su, T.-H.;Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:50Z |
Towards an HBV cure: State-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure
|
Beck, Juergen; Beck, Juergen; Levrero, Massimo; Kann, Michael; Knolle, Percy A.; Benkirane, Monsef; Benkirane, Monsef; Durantel, David; Durantel, David; Michel, Marie-Louise; Autran, Brigitte; Cosset, Francois-Loic; Strick-Marchand, Helene; Trepo, Christian; Trepo, Christian; Kao, Jia-Horng; Kao, Jia-Horng; Carrat, Fabrice; Carrat, Fabrice; Lacombe, Karine; Schinazi, Raymond F.; Schinazi, Raymond F.; Barre-Sinoussi, Francoise; Barre-Sinoussi, Francoise; Delfraissy, Jean-Francois; Delfraissy, Jean-Francois; Zoulim, Fabien; Zoulim, Fabien; Zeisel, Mirjam B.;Lucifora, Julie;Mason, William S.;Sureau, Camille;Beck, Juergen;Levrero, Massimo;Kann, Michael;Knolle, Percy A.;Benkirane, Monsef;Durantel, David;Michel, Marie-Louise;Autran, Brigitte;Cosset, Francois-Loic;Strick-Marchand, Helene;Trepo, Christian;Kao, Jia-Horng;Carrat, Fabrice;Lacombe, Karine;Schinazi, Raymond F.;Barre-Sinoussi, Francoise;Delfraissy, Jean-Francois;Zoulim, Fabien; Zeisel, Mirjam B.; JIA-HORNG KAO; Lucifora, Julie; Lucifora, Julie; Mason, William S.; Sureau, Camille; Sureau, Camille |
| 臺大學術典藏 |
2018-09-10T15:24:50Z |
Treating immune-tolerant Hepatitis B
|
Tseng, T.-C.;Kao, J.-H.; Tseng, T-C; JIA-HORNG KAO; Tseng, T-C; Kao, J-H; Kao, J-H |
| 臺大學術典藏 |
2018-09-10T15:24:50Z |
What can we learn from hepatitis B virus clinical cohorts?
|
JIA-HORNG KAO; Tseng, Tai-Chung; Kao, Jia-Horng; Kao, Jia-Horng; Lin, Chih-Lin;Tseng, Tai-Chung;Kao, Jia-Horng; Lin, Chih-Lin; Lin, Chih-Lin |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Hepatitis B virus genotypes and variants
|
Lin, Chih-Lin;Kao, Jia-Horng; Lin, Chih-Lin; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Hepatitis B virus infection and metabolic syndrome: Fact or fiction?
|
Wang, Chia-Chi;Tseng, Tai-Chung;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Tseng, Tai-Chung; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Perspectives and control of hepatitis B virus infection in Taiwan
|
Lin, Chih-Lin;Kao, Jia-Horng; Lin, Chih-Lin; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system
|
Liu, Jessica;Tseng, Tai-Chung;Yang, Hwai-I;Lee, Mei-Hsuan;Batrla-Utermann, Richard;Jen, Chin-Lan;Lu, Sheng-Nan;Wang, Li-Yu;You, San-Lin;Chen, Pei-Jer;Chen, Chien-Jen;Kao, Jia-Horng; Liu, Jessica; Liu, Jessica; PEI-JER CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Yang, Hwai-I; Lee, Mei-Hsuan; Lee, Mei-Hsuan; Batrla-Utermann, Richard; Jen, Chin-Lan; Jen, Chin-Lan; Lu, Sheng-Nan; Lu, Sheng-Nan; Wang, Li-Yu; You, San-Lin; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Chien-Jen; Chen, Chien-Jen; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection
|
Song, L.-W.;Liu, P.-G.;Liu, C.-J.;Zhang, T.-Y.;Cheng, X.-D.;Wu, H.-L.;Yang, H.-C.;Hao, X.-K.;Yuan, Q.;Zhang, J.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J.;Xia, N.-S.; HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Reimbursement policies in the Asia-Pacific for chronic hepatitis B
|
Lim, S.G.;Amarapurkar, D.N.;Chan, H.L.-Y.;Crawford, D.H.;Gane, E.J.;Han, K.-H.;Ahn, S.H.;Jafri, W.;Jia, J.;Kao, J.-H.;Lesmana, L.A.;Lesmana, C.R.A.;Mohamed, R.;Phiet, P.H.;Piratvisuth, T.;Sarin, S.K.;Sollarno, J.D.;Eguchi, Y.;Mahtab, M.-A.;Lee, K.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Hepatitis B vaccination and prevention of hepatocellular carcinoma
|
Kao, Jia-Horng; Kao, Jia-Horng; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
|
Bennett, H.;Waser, N.;Johnston, K.;Kao, J.-H.;Lim, Y.-S.;Duan, Z.-P.;Lee, Y.-J.;Wei, L.;Chen, C.-J.;Sievert, W.;Yuan, Y.;Li, H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma
|
Wang, Chia-Chi;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Yang, Hung-Chih; Kao, Jia-Horng; 楊宏志 |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B?
|
Lin, Chih-Lin;Kao, Jia-Horng; Lin, Chih-Lin; Lin, Chih-Lin; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:47Z |
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study
|
Huang, Y. -W.;Wang, T. -C.;Yang, S. -S.;Lin, S. -Y.;Fu, S. -C.;Hu, J. -T.;Liu, C. -J.;Kao, J. -H.;Chen, D. -S.; Huang, Y. -W.; Huang, Y. -W.; CHUN-JEN LIU; Wang, T. -C.; Wang, T. -C.; YI-WEN HUANG; DING-SHINN CHEN; Yang, S. -S.; Yang, S. -S.; JIA-HORNG KAO; Lin, S. -Y.; Fu, S. -C.; Fu, S. -C.; Hu, J. -T.; Hu, J. -T.; Liu, C. -J.; Liu, C. -J.; Kao, J. -H.; Kao, J. -H.; Chen, D. -S. |
| 臺大學術典藏 |
2018-09-10T15:24:41Z |
Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan
|
Chen, Chi-Ling; Chen, Chi-Ling; Yang, Jyh-Yuan; DING-SHINN CHEN; Yang, Jyh-Yuan; Lin, Szu-Fong; JIA-HORNG KAO; Lin, Szu-Fong; Sun, Chien-An; Sun, Chien-An; Bai, Chyi-Huey; You, San-Lin; Chen, Chien-Jen; Chen, Chien-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Pei-Jer; Chang, Sui-Yuan; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Ding-Shinn; PEI-JER CHEN; Chen, Chi-Ling;Yang, Jyh-Yuan;Lin, Szu-Fong;Sun, Chien-An;Bai, Chyi-Huey;You, San-Lin;Chen, Chien-Jen;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn; Chen, Chi-Ling |
| 臺大學術典藏 |
2018-09-10T15:24:41Z |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng;Liu, Wei-Liang;Chao, You-Chen;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; Liu, Wei-Liang; JIA-HORNG KAO; Chao, You-Chen; Lin, Hans Hsienhong; Abbas, Z.; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:18:59Z |
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
|
陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Liang, Cheng-Chao; HUNG-CHIH YANG; Liu, Chen-Hua; CHUN-JEN LIU; Chung, Chen-Shuan; PEI-JER CHEN; CHEN-HUA LIU; Lin, Cheng-Kuan; Chen, Hsiao-Jan; Su, Tung-Hung; DING-SHINN CHEN; TUNG-HUNG SU; Yang, Hung-Chih; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liang, Cheng-Chao;Liu, Chen-Hua;Chung, Chen-Shuan;Lin, Cheng-Kuan;Su, Tung-Hung;Yang, Hung-Chih;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liang, C.-C. and Liu, C.-H. and Chung, C.-S. and Lin, C.-K. and Su, T.-H. and Yang, H.-C. and Liu, C.-J. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T15:18:58Z |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
TUNG-HUNG SU; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Chen, Chi-Ling;Yang, Wan-Ting;Tsai, Cheng-Shiue;Kuo, Stephanie Fang-Tzu;Verbree, Femke Carolien;Su, Tung-Hung;Wang, Chia-Chi;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Tseng, T.-C. and Liu, C.-J. and Yang, H.-C. and Chen, C.-L. and Yang, W.-T. and Tsai, C.-S. and Kuo, S.F.-T. and Verbree, F.C. and Su, T.-H. and Wang, C.-C. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; HUNG-CHIH YANG; Tseng, Tai-Chung; Liu, Chun-Jen; CHUN-JEN LIU; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; Chen, Chi-Ling; Yang, Wan-Ting; DING-SHINN CHEN; Tsai, Cheng-Shiue |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?
|
Yang, Hung-Chih;Kao, Jia-Horng; Yang, Hung-Chih; HUNG-CHIH YANG; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, T.-H. and Shiau, C.-W. and Jao, P. and Liu, C.-H. and Liu, C.-J. and Tai, W.-T. and Jeng, Y.-M. and Yang, H.-C. and Tseng, T.-C. and Huang, H.-P. and Cheng, H.-R. and Chen, P.-J. and Chen, K.-F. and Kao, J.-H. and Chen, D.-S.; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; HUNG-CHIH YANG; Su, Tung-Hung; HSIANG-PO HUANG; Shiau, Chung-Wai; Jao, Ping; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; YUNG-MING JENG; Liu, Chun-Jen; CHEN-HUA LIU; Tai, Wei-Tien; DING-SHINN CHEN; Cheng, Wern-Cherng; Jeng, Yung-Ming; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T14:59:24Z |
HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?
|
Kao, Jia-Horng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:24Z |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B
|
Chien, Rong-Nan;Peng, Cheng-Yuan;Kao, Jia-Horng;Hu, Tsung-Hui;Lin, Chun-Che;Hu, Chi-Tan;Chen, Chi-Yi;Hsieh, Tsai-Yuan;Lin, Han-Chieh;Chuang, Wan-Longchien, Rong-Nan;Peng, Cheng-Yuan;Kao, Jia-Horng;Hu, Tsung-Hui;Lin, Chun-Che;Hu, Chi-Tan;Chen, Chi-Yi;Hsieh, Tsai-Yuan;Lin, Han-Chieh;Chuang, Wan-Long; JIA-HORNG KAO; Chien, Rong-Nan; Peng, Cheng-Yuan; Kao, Jia-Horng; Hu, Tsung-Hui; Lin, Chun-Che; Hu, Chi-Tan; Chen, Chi-Yi; Hsieh, Tsai-Yuan; Lin, Han-Chieh; Chuang, Wan-Long |
| 臺大學術典藏 |
2018-09-10T14:59:24Z |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, C.-L. and Liu, C.-H. and Wang, C.-C. and Liang, C.-C. and Su, T.-H. and Liu, C.-J. and Kao, J.-H.; Lin, Chih-Lin;Liu, Chen-Hua;Wang, Chia-Chi;Liang, Cheng-Chao;Su, Tung-Hung;Liu, Chun-Jen;Kao, Jia-Horng; 劉振驊;高嘉宏;蘇東弘;劉俊人; Lin, Shin-Yi; Lin, Chih-Lin; CHUN-JEN LIU; CHEN-HUA LIU; Tang, Sung-Chun; Liu, Chen-Hua; Liu, Chen-Hua; Wang, Chia-Chi; JIA-HORNG KAO; Tsai, Li-Kai; Liang, Cheng-Chao; Yeh, Shin-Joe; Su, Tung-Hung; Su, Tung-Hung; Shen, Li-Jiuan; Liu, Chun-Jen; Liu, Chun-Jen; Wu, Fe-Lin Lin; Kao, Jia-Horng; Jeng, Jiann-Shing; Kao, Jia-Horng; ?G???; ?L?z??; ???O??; ?????; ???|?g; ?H?R?S |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns, M.;Pol, S.;Jacobson, I.M.;Marcellin, P.;Gordon, S.C.;Peng, C.-Y.;Chang, T.-T.;Everson, G.T.;Heo, J.;Gerken, G.;Yoffe, B.;Towner, W.J.;Bourliere, M.;Metivier, S.;Chu, C.-J.;Sievert, W.;Bronowicki, J.-P.;Thabut, D.;Lee, Y.-J.;Kao, J.-H.;Mcphee, F.;Kopit, J.;Mendez, P.;Linaberry, M.;Hughes, E.;Noviello, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun;Kao, Jia-Horng; JIA-HORNG KAO; Yang, Sheng-Shun; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis
|
Wang, Chia-Chi;Hsieh, Tsung-Cheng;Tseng, Tai-Chung;Wang, Pin-Chao;Hsu, Ching-Sheng;Lin, Hans Hsienhong;Wang, Li-Yu;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Hsieh, Tsung-Cheng; Tseng, Tai-Chung; Wang, Pin-Chao; Hsu, Ching-Sheng; Lin, Hans Hsienhong; Wang, Li-Yu; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Peginterferon α in the treatment of chronic hepatitis B
|
Tseng, T.-C.; Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; JIA-HORNG KAO; Hsu, Shih-Jer; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, H.-R. and Kao, J.-H. and Wu, H.-L. and Chen, T.-C. and Tseng, T.-C. and Liu, C.-H. and Su, T.-H. and Chen, P.-J. and Chen, D.-S. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; Cheng, Huei-Ru; CHUN-JEN LIU; PEI-JER CHEN; Kao, Jia-Horng; CHEN-HUA LIU; Wu, Hui-Lin; DING-SHINN CHEN; Chen, Ting-Chih; Tseng, Tai-Chung; TUNG-HUNG SU; Liu, Chen-Hua; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Liu, Chen-Hua; Liu, Chen-Hua; Lin, L. -Y.; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng; 林亮宇; 陳保中; 林俊立; 江福田; 吳卓鍇; 黃瑞仁; 蔡佳醍; 陳祈玲; Tseng, T.-C. and Liu, C.-J. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Wan-Ting;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Wu, C. -K.; Tseng, Tai-Chung; HUNG-CHIH YANG; Liu, Chun-Jen; Yang, Y. -H.; Liu, Chun-Jen; CHUN-JEN LIU; Yang, Wan-Ting; Yang, Wan-Ting; PEI-JER CHEN; Lin, T. -T.; CHEN-HUA LIU; Tsai, C. -T.; Chen, Chi-Ling; Yang, Hung-Chih; DING-SHINN CHEN; Hwang, J. -J.; Yang, Hung-Chih; Su, Tung-Hung; TUNG-HUNG SU; Lin, J. -L.; Su, Tung-Hung; Wang, Chia-Chi; Chen, P. -C.; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Chiang, F. -T. |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study
|
Huang, Yi-Wen; Huang, Yi-Wen; Yang, Sien-Sing; DING-SHINN CHEN; JIA-HORNG KAO; Fu, Szu-Chieh; Wang, Ting-Chuan; Wang, Ting-Chuan; Hsu, Cheng-Kai; Chen, Ding-Shinn; Hu, Jui-Ting; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Huang, Yi-Wen;Yang, Sien-Sing;Fu, Szu-Chieh;Wang, Ting-Chuan;Hsu, Cheng-Kai;Chen, Ding-Shinn;Hu, Jui-Ting;Kao, Jia-Horng; YI-WEN HUANG |
| 臺大學術典藏 |
2018-09-10T14:53:28Z |
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance
|
Yang, Hung-Chih;Kao, Jia-Horng; Chen, M-J; HUNG-CHIH YANG; Yang, Hung-Chih; JIA-HORNG KAO; Wu, W. Y-Y; Kao, Jia-Horng; Yen, A. M-F; Fann, J. C-Y; Chen, S. L-S; Chiu, S. Y-H; Chen, H-H; Chiou, S-T; �����{; ���q�� |
| 臺大學術典藏 |
2018-09-10T14:51:19Z |
Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan
|
Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chien-Jen; Yang, Wei-Shiung; PEI-JER CHEN; WEI-SHIUNG YANG; Yang, Hwai-I; Chen, Chuen-Fei; DING-SHINN CHEN; JIA-HORNG KAO; You, San-Lin; Wang, Li-Yu; Lu, Sheng-Nan; Lu, Sheng-Nan; Liu, Chun-Jen; Yang, Wei-Shiung; CHUN-JEN LIU; Chen, Chi-Ling; Chen, Chi-Ling;Yang, Wei-Shiung;Yang, Hwai-I;Chen, Chuen-Fei;You, San-Lin;Wang, Li-Yu;Lu, Sheng-Nan;Liu, Chun-Jen;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn;Chen, Chien-Jen; Chen, Chi-Ling |
显示项目 811-860 / 1180 (共24页)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每页显示[10|25|50]项目
|
